 The novel and original aspect of this investigator initiated study is the focus on incretin pathophysiology in an uraemic milieu. In this first of 5 substudies separate notification and registration the investigators explore the incretin effect. Our hypothesis is that it is impaired in non-diabetic patients in chronic dialysis treatment. 